mRNA |
PD 153035 |
CTRPv2 |
pan-cancer |
AAC |
0.023 |
0.6 |
mRNA |
Gefitinib |
GDSC1000 |
pan-cancer |
AAC |
0.018 |
0.6 |
mRNA |
elocalcitol |
CTRPv2 |
pan-cancer |
AAC |
-0.019 |
0.6 |
mRNA |
parbendazole |
CTRPv2 |
pan-cancer |
AAC |
-0.017 |
0.6 |
mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.019 |
0.6 |
mRNA |
BRD9876:MK-1775 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.068 |
0.6 |
mRNA |
BIRB 0796 |
CTRPv2 |
pan-cancer |
AAC |
-0.021 |
0.6 |
mRNA |
Epothilone B |
GDSC1000 |
pan-cancer |
AAC |
0.019 |
0.6 |
mRNA |
Roscovitine |
GDSC1000 |
pan-cancer |
AAC |
0.029 |
0.6 |
mRNA |
BRD-K84807411 |
CTRPv2 |
pan-cancer |
AAC |
0.04 |
0.6 |